• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过开发针对禽流感病毒的疫苗做好大流行的准备。

Pandemic preparedness through vaccine development for avian influenza viruses.

机构信息

Department of Population Health, College of Veterinary Medicine, University of Georgia, Athens, GA, USA.

出版信息

Hum Vaccin Immunother. 2024 Dec 31;20(1):2347019. doi: 10.1080/21645515.2024.2347019. Epub 2024 May 28.

DOI:10.1080/21645515.2024.2347019
PMID:38807261
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11141480/
Abstract

Influenza A viruses pose a significant threat to global health, impacting both humans and animals. Zoonotic transmission, particularly from swine and avian species, is the primary source of human influenza outbreaks. Notably, avian influenza viruses of the H5N1, H7N9, and H9N2 subtypes are of pandemic concern through their global spread and sporadic human infections. Preventing and controlling these viruses is critical due to their high threat level. Vaccination remains the most effective strategy for influenza prevention and control in humans, despite varying vaccine efficacy across strains. This review focuses specifically on pandemic preparedness for avian influenza viruses. We delve into vaccines tested in animal models and summarize clinical trials conducted on H5N1, H7N9, and H9N2 vaccines in humans.

摘要

甲型流感病毒对全球健康构成重大威胁,影响人类和动物。人畜共患病传播,特别是猪和禽种的传播,是人类流感爆发的主要来源。值得注意的是,H5N1、H7N9 和 H9N2 亚型的禽流感病毒通过其在全球的传播和偶发的人类感染而引起大流行的关注。由于这些病毒的高威胁水平,预防和控制这些病毒至关重要。尽管不同菌株的疫苗效果存在差异,但疫苗接种仍然是预防和控制人类流感的最有效策略。本综述专门针对禽流感病毒的大流行准备情况。我们深入研究了在动物模型中测试的疫苗,并总结了在人类中进行的针对 H5N1、H7N9 和 H9N2 疫苗的临床试验。

相似文献

1
Pandemic preparedness through vaccine development for avian influenza viruses.通过开发针对禽流感病毒的疫苗做好大流行的准备。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2347019. doi: 10.1080/21645515.2024.2347019. Epub 2024 May 28.
2
Are we serologically prepared against an avian influenza pandemic and could seasonal flu vaccines help us?我们在血清学上是否对禽流感大流行做好了准备,季节性流感疫苗能帮助我们吗?
mBio. 2025 Feb 5;16(2):e0372124. doi: 10.1128/mbio.03721-24. Epub 2024 Dec 31.
3
Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.人畜共患流感病毒的抗原和基因特征以及大流行防范候选疫苗病毒的研发。
Wkly Epidemiol Rec. 2014 Oct 17;89(42):457-64.
4
Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.人畜共患流感病毒的抗原和基因特征以及大流行防范候选疫苗病毒的研发。
Wkly Epidemiol Rec. 2015 Mar 20;90(12):109-20.
5
Antigenic and genetic characteristics of influenza A(H5N1) and influenza A(H9N2) viruses for development of candidate vaccines viruses for pandemic preparedness - February 2011.用于大流行防范的甲型流感病毒A(H5N1)和A(H9N2)候选疫苗病毒研发的抗原及基因特征——2011年2月
Wkly Epidemiol Rec. 2011 Mar 11;86(11):93-100.
6
Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.人畜共患流感病毒的抗原和基因特征以及用于大流行防范的候选疫苗病毒的研发。
Wkly Epidemiol Rec. 2011 Oct 21;86(43):469-80.
7
Zoonotic influenza viruses: antigenic and genetic characteristics and development of candidate vaccine viruses for pandemic preparedness.人畜共患流感病毒:抗原和遗传特征以及用于大流行防范的候选疫苗病毒的研发
Wkly Epidemiol Rec. 2016 Mar 18;91(11):133-43.
8
Zoonotic influenza viruses: antigenic and genetic characteristics and development of candidate vaccine viruses for pandemic preparedness.人畜共患流感病毒:抗原和遗传特征以及大流行防范候选疫苗病毒的研发
Wkly Epidemiol Rec. 2016 Oct 16;91(42):485-99.
9
Development of a dual-protective live attenuated vaccine against H5N1 and H9N2 avian influenza viruses by modifying the NS1 gene.通过修饰NS1基因开发一种针对H5N1和H9N2禽流感病毒的双保护减毒活疫苗。
Arch Virol. 2015 Jul;160(7):1729-40. doi: 10.1007/s00705-015-2442-y. Epub 2015 May 12.
10
Avian Influenza Virus A(H5Nx) and Prepandemic Candidate Vaccines: State of the Art.禽流感病毒 A(H5Nx)和大流行前候选疫苗:最新进展。
Int J Mol Sci. 2024 Aug 5;25(15):8550. doi: 10.3390/ijms25158550.

引用本文的文献

1
Streamlined CRISPR-based assays for detection and subtyping of avian influenza.用于禽流感检测和亚型分型的简化型基于CRISPR的检测方法
medRxiv. 2025 Aug 26:2025.08.21.25334105. doi: 10.1101/2025.08.21.25334105.
2
Microbiome-Immune Interaction and Harnessing for Next-Generation Vaccines Against Highly Pathogenic Avian Influenza in Poultry.微生物群-免疫相互作用及其在开发家禽高致病性禽流感下一代疫苗中的应用
Vaccines (Basel). 2025 Aug 6;13(8):837. doi: 10.3390/vaccines13080837.
3
Immune Responses of Dendritic Cells to Zoonotic DNA and RNA Viruses.

本文引用的文献

1
Development of a nucleoside-modified mRNA vaccine against clade 2.3.4.4b H5 highly pathogenic avian influenza virus.针对 2.3.4.4b 谱系 H5 高致病性禽流感病毒的核苷修饰 mRNA 疫苗的研制。
Nat Commun. 2024 May 23;15(1):4350. doi: 10.1038/s41467-024-48555-z.
2
An mRNA-based broad-spectrum vaccine candidate confers cross-protection against heterosubtypic influenza A viruses.一种基于 mRNA 的广谱疫苗候选物对异源亚型流感 A 病毒提供交叉保护。
Emerg Microbes Infect. 2023 Dec;12(2):2256422. doi: 10.1080/22221751.2023.2256422. Epub 2023 Sep 6.
3
Genetic characterization of a new candidate hemagglutinin subtype of influenza A viruses.
树突状细胞对人畜共患DNA和RNA病毒的免疫反应
Vet Sci. 2025 Jul 24;12(8):692. doi: 10.3390/vetsci12080692.
4
Immunogenicity of Matrix Protein 2 Ectodomain (M2e) Displayed on Nodavirus-like Particles as Avian Influenza Vaccine for Poultry.作为家禽禽流感疫苗的诺达病毒样颗粒展示的基质蛋白2胞外域(M2e)的免疫原性
Vaccines (Basel). 2025 Jun 27;13(7):701. doi: 10.3390/vaccines13070701.
5
H5N1 Avian Influenza: A Narrative Review of Scientific Advances and Global Policy Challenges.H5N1禽流感:科学进展与全球政策挑战的叙述性综述
Viruses. 2025 Jun 29;17(7):927. doi: 10.3390/v17070927.
6
Experimental infection and viral pathogenesis of a human isolate of H5N1 highly pathogenic avian influenza strain in Jersey cows.H5N1高致病性禽流感病毒人源分离株在泽西奶牛中的实验性感染及病毒致病性研究
Res Sq. 2025 Jun 25:rs.3.rs-6915991. doi: 10.21203/rs.3.rs-6915991/v1.
7
Enhancing the response to avian influenza in the US and globally.加强美国及全球对禽流感的应对能力。
Lancet Reg Health Am. 2025 Apr 28;46:101100. doi: 10.1016/j.lana.2025.101100. eCollection 2025 Jun.
8
Design, Synthesis and Evaluation of a Candidate Fusion Epitopic Construct Vaccine Based on M2e, HA1, HA2, NA and NP Fragments of the Highly Pathogenic Avian H5N1 Influenza Virus.基于高致病性H5N1禽流感病毒M2e、HA1、HA2、NA和NP片段的候选融合表位构建疫苗的设计、合成与评价
Arch Razi Inst. 2024 Aug 1;79(4):849-856. doi: 10.32592/ARI.2024.79.4.849. eCollection 2024 Aug.
9
Visualizing and analyzing 3D biomolecular structures using Mol* at RCSB.org: Influenza A H5N1 virus proteome case study.在RCSB.org网站使用Mol*可视化和分析三维生物分子结构:甲型H5N1流感病毒蛋白质组案例研究
Protein Sci. 2025 Apr;34(4):e70093. doi: 10.1002/pro.70093.
10
Pandemic preparedness of effective vaccines for the outbreak of newly H5N1 highly pathogenic avian influenza virus.针对新出现的H5N1高致病性禽流感病毒疫情的有效疫苗的大流行防范。
Virol Sin. 2024 Dec;39(6):981-985. doi: 10.1016/j.virs.2024.11.005. Epub 2024 Nov 30.
新型候选血凝素亚型流感 A 病毒的遗传特征。
Emerg Microbes Infect. 2023 Dec;12(2):2225645. doi: 10.1080/22221751.2023.2225645.
4
Antibody responses against heterologous H5N1 strains for an MF59-adjuvanted cell culture-derived H5N1 (aH5n1c) influenza vaccine in adults and older adults.在成年人和老年人中,MF59 佐剂的细胞培养衍生 H5N1(aH5n1c)流感疫苗对异源 H5N1 株的抗体反应。
Hum Vaccin Immunother. 2023 Dec 31;19(1):2193119. doi: 10.1080/21645515.2023.2193119. Epub 2023 Apr 14.
5
First case of human infection with highly pathogenic H5 avian Influenza A virus in South America: A new zoonotic pandemic threat for 2023?南美洲首例人类感染高致病性H5甲型禽流感病毒:2023年新的人畜共患大流行威胁?
J Travel Med. 2023 Sep 5;30(5). doi: 10.1093/jtm/taad032.
6
Dendritic cell-natural killer cell cross-talk modulates T cell activation in response to influenza A viral infection.树突状细胞-自然杀伤细胞相互作用调节 T 细胞对甲型流感病毒感染的激活。
Front Immunol. 2022 Dec 22;13:1006998. doi: 10.3389/fimmu.2022.1006998. eCollection 2022.
7
Alarming situation of emerging H5 and H7 avian influenza and effective control strategies.令人担忧的 H5 和 H7 禽流感新发病况和有效控制策略。
Emerg Microbes Infect. 2023 Dec;12(1):2155072. doi: 10.1080/22221751.2022.2155072.
8
A replication-deficient H9N2 influenza virus carrying H5 hemagglutinin conferred protection against H9N2 and H5N1 influenza viruses in mice.携带H5血凝素的复制缺陷型H9N2流感病毒可使小鼠对H9N2和H5N1流感病毒产生免疫保护。
Front Microbiol. 2022 Nov 15;13:1042916. doi: 10.3389/fmicb.2022.1042916. eCollection 2022.
9
Dose-sparing effect of two adjuvant formulations with a pandemic influenza A/H7N9 vaccine: A randomized, double-blind, placebo-controlled, phase 1 clinical trial.两种佐剂剂型与季节性流感 A/H7N9 疫苗联用的剂量节约效应:一项随机、双盲、安慰剂对照、1 期临床试验。
PLoS One. 2022 Oct 18;17(10):e0274943. doi: 10.1371/journal.pone.0274943. eCollection 2022.
10
The role of cell-mediated immunity against influenza and its implications for vaccine evaluation.细胞介导免疫对流感的作用及其对疫苗评估的影响。
Front Immunol. 2022 Aug 16;13:959379. doi: 10.3389/fimmu.2022.959379. eCollection 2022.